nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—CYP26A1—esophageal cancer	0.758	1	CbGaD
Acitretin—CYP26A1—bronchus—esophageal cancer	0.00389	0.127	CbGeAlD
Acitretin—CYP26A1—trachea—esophageal cancer	0.0035	0.114	CbGeAlD
Acitretin—RXRG—neck—esophageal cancer	0.00314	0.102	CbGeAlD
Acitretin—Alitretinoin—CRABP1—esophageal cancer	0.0024	0.367	CrCbGaD
Acitretin—RBP1—epithelium—esophageal cancer	0.00236	0.0769	CbGeAlD
Acitretin—RBP1—smooth muscle tissue—esophageal cancer	0.00228	0.0741	CbGeAlD
Acitretin—RARB—bronchus—esophageal cancer	0.00215	0.07	CbGeAlD
Acitretin—Vitamin A—CYP26A1—esophageal cancer	0.00182	0.279	CrCbGaD
Acitretin—RBP1—digestive system—esophageal cancer	0.0018	0.0585	CbGeAlD
Acitretin—Tretinoin—CRABP1—esophageal cancer	0.00169	0.258	CrCbGaD
Acitretin—RBP1—lung—esophageal cancer	0.0015	0.0488	CbGeAlD
Acitretin—RARB—lung—esophageal cancer	0.00139	0.0452	CbGeAlD
Acitretin—RARG—digestive system—esophageal cancer	0.00136	0.0441	CbGeAlD
Acitretin—RXRB—lung—esophageal cancer	0.00128	0.0415	CbGeAlD
Acitretin—RARG—lung—esophageal cancer	0.00113	0.0369	CbGeAlD
Acitretin—RARA—lung—esophageal cancer	0.00106	0.0347	CbGeAlD
Acitretin—RBP1—lymph node—esophageal cancer	0.00103	0.0334	CbGeAlD
Acitretin—RARB—lymph node—esophageal cancer	0.000949	0.0309	CbGeAlD
Acitretin—RARG—lymph node—esophageal cancer	0.000775	0.0252	CbGeAlD
Acitretin—RARA—lymph node—esophageal cancer	0.000728	0.0237	CbGeAlD
Acitretin—Fungal infection—Capecitabine—esophageal cancer	0.000472	0.00567	CcSEcCtD
Acitretin—Skin ulcer—Capecitabine—esophageal cancer	0.000469	0.00562	CcSEcCtD
Acitretin—Otitis media—Capecitabine—esophageal cancer	0.000469	0.00562	CcSEcCtD
Acitretin—Hyperaesthesia—Capecitabine—esophageal cancer	0.000465	0.00558	CcSEcCtD
Acitretin—Febrile neutropenia—Methotrexate—esophageal cancer	0.000451	0.00542	CcSEcCtD
Acitretin—Ageusia—Capecitabine—esophageal cancer	0.00045	0.0054	CcSEcCtD
Acitretin—Rigors—Capecitabine—esophageal cancer	0.000447	0.00536	CcSEcCtD
Acitretin—Vaginal discharge—Methotrexate—esophageal cancer	0.000446	0.00536	CcSEcCtD
Acitretin—Dysphonia—Capecitabine—esophageal cancer	0.000443	0.00532	CcSEcCtD
Acitretin—Psoriasis—Methotrexate—esophageal cancer	0.000432	0.00519	CcSEcCtD
Acitretin—Eye irritation—Capecitabine—esophageal cancer	0.000427	0.00513	CcSEcCtD
Acitretin—Embolism—Methotrexate—esophageal cancer	0.000423	0.00508	CcSEcCtD
Acitretin—Nail disorder—Methotrexate—esophageal cancer	0.000419	0.00503	CcSEcCtD
Acitretin—Proteinuria—Capecitabine—esophageal cancer	0.000415	0.00498	CcSEcCtD
Acitretin—ALB—lymph node—esophageal cancer	0.000411	0.0134	CbGeAlD
Acitretin—Tretinoin—CYP2A6—esophageal cancer	0.00041	0.0627	CrCbGaD
Acitretin—Protein urine present—Capecitabine—esophageal cancer	0.000409	0.00491	CcSEcCtD
Acitretin—Cyst—Methotrexate—esophageal cancer	0.000406	0.00488	CcSEcCtD
Acitretin—Deafness—Cisplatin—esophageal cancer	0.000402	0.00482	CcSEcCtD
Acitretin—Herpes simplex—Capecitabine—esophageal cancer	0.000396	0.00475	CcSEcCtD
Acitretin—Cyanosis—Methotrexate—esophageal cancer	0.000384	0.0046	CcSEcCtD
Acitretin—Cataract—Capecitabine—esophageal cancer	0.000383	0.0046	CcSEcCtD
Acitretin—Bone pain—Capecitabine—esophageal cancer	0.000381	0.00457	CcSEcCtD
Acitretin—Gait disturbance—Capecitabine—esophageal cancer	0.000374	0.00449	CcSEcCtD
Acitretin—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000367	0.0044	CcSEcCtD
Acitretin—Melaena—Capecitabine—esophageal cancer	0.000356	0.00428	CcSEcCtD
Acitretin—Influenza like illness—Capecitabine—esophageal cancer	0.000354	0.00425	CcSEcCtD
Acitretin—Fungal infection—Methotrexate—esophageal cancer	0.000352	0.00422	CcSEcCtD
Acitretin—Skin ulcer—Methotrexate—esophageal cancer	0.000349	0.00419	CcSEcCtD
Acitretin—Candida infection—Capecitabine—esophageal cancer	0.000348	0.00418	CcSEcCtD
Acitretin—Skin exfoliation—Capecitabine—esophageal cancer	0.000348	0.00418	CcSEcCtD
Acitretin—Gingivitis—Methotrexate—esophageal cancer	0.000346	0.00415	CcSEcCtD
Acitretin—Dry eye—Capecitabine—esophageal cancer	0.000337	0.00404	CcSEcCtD
Acitretin—Blood creatinine increased—Cisplatin—esophageal cancer	0.000337	0.00404	CcSEcCtD
Acitretin—Oesophagitis—Capecitabine—esophageal cancer	0.000333	0.004	CcSEcCtD
Acitretin—Mouth ulceration—Capecitabine—esophageal cancer	0.00033	0.00396	CcSEcCtD
Acitretin—Ear pain—Capecitabine—esophageal cancer	0.00031	0.00373	CcSEcCtD
Acitretin—Proteinuria—Methotrexate—esophageal cancer	0.000309	0.00371	CcSEcCtD
Acitretin—Protein urine present—Methotrexate—esophageal cancer	0.000305	0.00366	CcSEcCtD
Acitretin—Diabetes mellitus—Capecitabine—esophageal cancer	0.000304	0.00365	CcSEcCtD
Acitretin—Pancreatitis—Cisplatin—esophageal cancer	0.000304	0.00365	CcSEcCtD
Acitretin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000303	0.00364	CcSEcCtD
Acitretin—Sweating increased—Cisplatin—esophageal cancer	0.000302	0.00363	CcSEcCtD
Acitretin—Photosensitivity—Capecitabine—esophageal cancer	0.000302	0.00362	CcSEcCtD
Acitretin—Bone disorder—Methotrexate—esophageal cancer	0.000301	0.00361	CcSEcCtD
Acitretin—Gastroenteritis—Capecitabine—esophageal cancer	0.000299	0.00359	CcSEcCtD
Acitretin—Deafness—Capecitabine—esophageal cancer	0.000296	0.00355	CcSEcCtD
Acitretin—Vascular purpura—Capecitabine—esophageal cancer	0.000296	0.00355	CcSEcCtD
Acitretin—Pancytopenia—Cisplatin—esophageal cancer	0.000295	0.00354	CcSEcCtD
Acitretin—Glossitis—Methotrexate—esophageal cancer	0.000295	0.00354	CcSEcCtD
Acitretin—Herpes simplex—Methotrexate—esophageal cancer	0.000295	0.00354	CcSEcCtD
Acitretin—Eye pain—Capecitabine—esophageal cancer	0.000293	0.00352	CcSEcCtD
Acitretin—Libido decreased—Capecitabine—esophageal cancer	0.000286	0.00343	CcSEcCtD
Acitretin—Hot flush—Capecitabine—esophageal cancer	0.000283	0.0034	CcSEcCtD
Acitretin—Increased appetite—Capecitabine—esophageal cancer	0.000282	0.00338	CcSEcCtD
Acitretin—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000281	0.00337	CcSEcCtD
Acitretin—Menopausal symptoms—Capecitabine—esophageal cancer	0.000281	0.00337	CcSEcCtD
Acitretin—Thirst—Capecitabine—esophageal cancer	0.000278	0.00334	CcSEcCtD
Acitretin—Vasculitis—Methotrexate—esophageal cancer	0.000278	0.00334	CcSEcCtD
Acitretin—Dermatitis bullous—Capecitabine—esophageal cancer	0.000277	0.00333	CcSEcCtD
Acitretin—Blood uric acid increased—Methotrexate—esophageal cancer	0.000277	0.00332	CcSEcCtD
Acitretin—Purpura—Capecitabine—esophageal cancer	0.000275	0.0033	CcSEcCtD
Acitretin—Arthritis—Capecitabine—esophageal cancer	0.000272	0.00327	CcSEcCtD
Acitretin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000271	0.00326	CcSEcCtD
Acitretin—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00027	0.00324	CcSEcCtD
Acitretin—Stomatitis—Cisplatin—esophageal cancer	0.00027	0.00324	CcSEcCtD
Acitretin—Conjunctivitis—Cisplatin—esophageal cancer	0.000269	0.00323	CcSEcCtD
Acitretin—Melaena—Methotrexate—esophageal cancer	0.000265	0.00318	CcSEcCtD
Acitretin—Diplopia—Capecitabine—esophageal cancer	0.000265	0.00318	CcSEcCtD
Acitretin—Osteoarthritis—Capecitabine—esophageal cancer	0.000265	0.00318	CcSEcCtD
Acitretin—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000263	0.00315	CcSEcCtD
Acitretin—Migraine—Capecitabine—esophageal cancer	0.000261	0.00313	CcSEcCtD
Acitretin—Skin exfoliation—Methotrexate—esophageal cancer	0.000259	0.00311	CcSEcCtD
Acitretin—Blood creatinine increased—Capecitabine—esophageal cancer	0.000248	0.00298	CcSEcCtD
Acitretin—Mouth ulceration—Methotrexate—esophageal cancer	0.000246	0.00295	CcSEcCtD
Acitretin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000244	0.00293	CcSEcCtD
Acitretin—Dry skin—Capecitabine—esophageal cancer	0.000243	0.00291	CcSEcCtD
Acitretin—Visual impairment—Cisplatin—esophageal cancer	0.00024	0.00287	CcSEcCtD
Acitretin—Gastritis—Capecitabine—esophageal cancer	0.000234	0.00281	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000234	0.0028	CcSEcCtD
Acitretin—Muscular weakness—Capecitabine—esophageal cancer	0.000234	0.0028	CcSEcCtD
Acitretin—Eye disorder—Cisplatin—esophageal cancer	0.000232	0.00279	CcSEcCtD
Acitretin—Tinnitus—Cisplatin—esophageal cancer	0.000232	0.00278	CcSEcCtD
Acitretin—Flushing—Cisplatin—esophageal cancer	0.000231	0.00277	CcSEcCtD
Acitretin—Diabetes mellitus—Methotrexate—esophageal cancer	0.000227	0.00272	CcSEcCtD
Acitretin—Photosensitivity—Methotrexate—esophageal cancer	0.000225	0.00269	CcSEcCtD
Acitretin—Immune system disorder—Cisplatin—esophageal cancer	0.000224	0.00269	CcSEcCtD
Acitretin—Sweating increased—Capecitabine—esophageal cancer	0.000223	0.00268	CcSEcCtD
Acitretin—Alopecia—Cisplatin—esophageal cancer	0.00022	0.00264	CcSEcCtD
Acitretin—Pancytopenia—Capecitabine—esophageal cancer	0.000217	0.00261	CcSEcCtD
Acitretin—Alitretinoin—ABCB1—esophageal cancer	0.000217	0.0331	CrCbGaD
Acitretin—Erythema—Cisplatin—esophageal cancer	0.000216	0.0026	CcSEcCtD
Acitretin—Dysuria—Capecitabine—esophageal cancer	0.000214	0.00257	CcSEcCtD
Acitretin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000209	0.00251	CcSEcCtD
Acitretin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000209	0.00251	CcSEcCtD
Acitretin—Weight increased—Capecitabine—esophageal cancer	0.000208	0.0025	CcSEcCtD
Acitretin—Visual disturbance—Methotrexate—esophageal cancer	0.000208	0.0025	CcSEcCtD
Acitretin—Muscle spasms—Cisplatin—esophageal cancer	0.000208	0.0025	CcSEcCtD
Acitretin—Weight decreased—Capecitabine—esophageal cancer	0.000207	0.00249	CcSEcCtD
Acitretin—Vision blurred—Cisplatin—esophageal cancer	0.000204	0.00245	CcSEcCtD
Acitretin—Depression—Capecitabine—esophageal cancer	0.000203	0.00244	CcSEcCtD
Acitretin—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000201	0.00241	CcSEcCtD
Acitretin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000201	0.00241	CcSEcCtD
Acitretin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.0002	0.0024	CcSEcCtD
Acitretin—Stomatitis—Capecitabine—esophageal cancer	0.000199	0.00239	CcSEcCtD
Acitretin—Jaundice—Capecitabine—esophageal cancer	0.000199	0.00239	CcSEcCtD
Acitretin—Urinary tract infection—Capecitabine—esophageal cancer	0.000198	0.00238	CcSEcCtD
Acitretin—Conjunctivitis—Capecitabine—esophageal cancer	0.000198	0.00238	CcSEcCtD
Acitretin—Osteoarthritis—Methotrexate—esophageal cancer	0.000197	0.00237	CcSEcCtD
Acitretin—Malaise—Cisplatin—esophageal cancer	0.000195	0.00234	CcSEcCtD
Acitretin—Haematuria—Capecitabine—esophageal cancer	0.000195	0.00234	CcSEcCtD
Acitretin—Epistaxis—Capecitabine—esophageal cancer	0.000192	0.00231	CcSEcCtD
Acitretin—Myalgia—Cisplatin—esophageal cancer	0.000184	0.00221	CcSEcCtD
Acitretin—Haemoglobin—Capecitabine—esophageal cancer	0.000184	0.00221	CcSEcCtD
Acitretin—Rhinitis—Capecitabine—esophageal cancer	0.000184	0.0022	CcSEcCtD
Acitretin—Anxiety—Cisplatin—esophageal cancer	0.000184	0.0022	CcSEcCtD
Acitretin—Haemorrhage—Capecitabine—esophageal cancer	0.000183	0.0022	CcSEcCtD
Acitretin—Hepatitis—Capecitabine—esophageal cancer	0.000183	0.0022	CcSEcCtD
Acitretin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000182	0.00219	CcSEcCtD
Acitretin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000182	0.00218	CcSEcCtD
Acitretin—Discomfort—Cisplatin—esophageal cancer	0.000182	0.00218	CcSEcCtD
Acitretin—Pharyngitis—Capecitabine—esophageal cancer	0.000182	0.00218	CcSEcCtD
Acitretin—Oedema peripheral—Capecitabine—esophageal cancer	0.00018	0.00217	CcSEcCtD
Acitretin—Oedema—Cisplatin—esophageal cancer	0.000177	0.00212	CcSEcCtD
Acitretin—Visual impairment—Capecitabine—esophageal cancer	0.000177	0.00212	CcSEcCtD
Acitretin—Infection—Cisplatin—esophageal cancer	0.000175	0.00211	CcSEcCtD
Acitretin—Skin disorder—Cisplatin—esophageal cancer	0.000172	0.00206	CcSEcCtD
Acitretin—Eye disorder—Capecitabine—esophageal cancer	0.000171	0.00205	CcSEcCtD
Acitretin—Tinnitus—Capecitabine—esophageal cancer	0.000171	0.00205	CcSEcCtD
Acitretin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000171	0.00205	CcSEcCtD
Acitretin—Flushing—Capecitabine—esophageal cancer	0.00017	0.00204	CcSEcCtD
Acitretin—Anorexia—Cisplatin—esophageal cancer	0.000168	0.00202	CcSEcCtD
Acitretin—Pancreatitis—Methotrexate—esophageal cancer	0.000167	0.002	CcSEcCtD
Acitretin—Angiopathy—Capecitabine—esophageal cancer	0.000166	0.00199	CcSEcCtD
Acitretin—Immune system disorder—Capecitabine—esophageal cancer	0.000165	0.00199	CcSEcCtD
Acitretin—Chills—Capecitabine—esophageal cancer	0.000164	0.00197	CcSEcCtD
Acitretin—Alopecia—Capecitabine—esophageal cancer	0.000162	0.00194	CcSEcCtD
Acitretin—Pancytopenia—Methotrexate—esophageal cancer	0.000162	0.00194	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000161	0.00193	CcSEcCtD
Acitretin—Erythema—Capecitabine—esophageal cancer	0.000159	0.00191	CcSEcCtD
Acitretin—Dysuria—Methotrexate—esophageal cancer	0.000159	0.00191	CcSEcCtD
Acitretin—Paraesthesia—Cisplatin—esophageal cancer	0.000159	0.0019	CcSEcCtD
Acitretin—Erectile dysfunction—Methotrexate—esophageal cancer	0.000157	0.00188	CcSEcCtD
Acitretin—Dysgeusia—Capecitabine—esophageal cancer	0.000156	0.00187	CcSEcCtD
Acitretin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000156	0.00187	CcSEcCtD
Acitretin—Back pain—Capecitabine—esophageal cancer	0.000154	0.00185	CcSEcCtD
Acitretin—Decreased appetite—Cisplatin—esophageal cancer	0.000153	0.00184	CcSEcCtD
Acitretin—Muscle spasms—Capecitabine—esophageal cancer	0.000153	0.00184	CcSEcCtD
Acitretin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000152	0.00183	CcSEcCtD
Acitretin—Depression—Methotrexate—esophageal cancer	0.000151	0.00182	CcSEcCtD
Acitretin—Pain—Cisplatin—esophageal cancer	0.000151	0.00181	CcSEcCtD
Acitretin—Vision blurred—Capecitabine—esophageal cancer	0.00015	0.0018	CcSEcCtD
Acitretin—Stomatitis—Methotrexate—esophageal cancer	0.000148	0.00178	CcSEcCtD
Acitretin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000148	0.00178	CcSEcCtD
Acitretin—Conjunctivitis—Methotrexate—esophageal cancer	0.000148	0.00177	CcSEcCtD
Acitretin—Feeling abnormal—Cisplatin—esophageal cancer	0.000146	0.00175	CcSEcCtD
Acitretin—Haematuria—Methotrexate—esophageal cancer	0.000145	0.00174	CcSEcCtD
Acitretin—Malaise—Capecitabine—esophageal cancer	0.000144	0.00173	CcSEcCtD
Acitretin—Epistaxis—Methotrexate—esophageal cancer	0.000143	0.00172	CcSEcCtD
Acitretin—Body temperature increased—Cisplatin—esophageal cancer	0.00014	0.00168	CcSEcCtD
Acitretin—Cough—Capecitabine—esophageal cancer	0.000139	0.00167	CcSEcCtD
Acitretin—Haemoglobin—Methotrexate—esophageal cancer	0.000137	0.00165	CcSEcCtD
Acitretin—Haemorrhage—Methotrexate—esophageal cancer	0.000136	0.00164	CcSEcCtD
Acitretin—Hepatitis—Methotrexate—esophageal cancer	0.000136	0.00164	CcSEcCtD
Acitretin—Chest pain—Capecitabine—esophageal cancer	0.000136	0.00163	CcSEcCtD
Acitretin—Myalgia—Capecitabine—esophageal cancer	0.000136	0.00163	CcSEcCtD
Acitretin—Arthralgia—Capecitabine—esophageal cancer	0.000136	0.00163	CcSEcCtD
Acitretin—Pharyngitis—Methotrexate—esophageal cancer	0.000135	0.00162	CcSEcCtD
Acitretin—Anxiety—Capecitabine—esophageal cancer	0.000135	0.00162	CcSEcCtD
Acitretin—Discomfort—Capecitabine—esophageal cancer	0.000134	0.00161	CcSEcCtD
Acitretin—Dry mouth—Capecitabine—esophageal cancer	0.000133	0.00159	CcSEcCtD
Acitretin—Visual impairment—Methotrexate—esophageal cancer	0.000131	0.00158	CcSEcCtD
Acitretin—Oedema—Capecitabine—esophageal cancer	0.00013	0.00156	CcSEcCtD
Acitretin—Hypersensitivity—Cisplatin—esophageal cancer	0.00013	0.00156	CcSEcCtD
Acitretin—Infection—Capecitabine—esophageal cancer	0.000129	0.00155	CcSEcCtD
Acitretin—Eye disorder—Methotrexate—esophageal cancer	0.000127	0.00153	CcSEcCtD
Acitretin—Tinnitus—Methotrexate—esophageal cancer	0.000127	0.00153	CcSEcCtD
Acitretin—Asthenia—Cisplatin—esophageal cancer	0.000127	0.00152	CcSEcCtD
Acitretin—Skin disorder—Capecitabine—esophageal cancer	0.000126	0.00152	CcSEcCtD
Acitretin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000126	0.00151	CcSEcCtD
Acitretin—Anorexia—Capecitabine—esophageal cancer	0.000124	0.00149	CcSEcCtD
Acitretin—Angiopathy—Methotrexate—esophageal cancer	0.000124	0.00149	CcSEcCtD
Acitretin—Immune system disorder—Methotrexate—esophageal cancer	0.000123	0.00148	CcSEcCtD
Acitretin—Chills—Methotrexate—esophageal cancer	0.000122	0.00147	CcSEcCtD
Acitretin—Diarrhoea—Cisplatin—esophageal cancer	0.000121	0.00145	CcSEcCtD
Acitretin—Alopecia—Methotrexate—esophageal cancer	0.000121	0.00145	CcSEcCtD
Acitretin—Erythema—Methotrexate—esophageal cancer	0.000119	0.00142	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000119	0.00142	CcSEcCtD
Acitretin—Insomnia—Capecitabine—esophageal cancer	0.000118	0.00141	CcSEcCtD
Acitretin—Paraesthesia—Capecitabine—esophageal cancer	0.000117	0.0014	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—esophageal cancer	0.000116	0.0014	CcSEcCtD
Acitretin—Back pain—Methotrexate—esophageal cancer	0.000115	0.00138	CcSEcCtD
Acitretin—Dyspepsia—Capecitabine—esophageal cancer	0.000115	0.00138	CcSEcCtD
Acitretin—Decreased appetite—Capecitabine—esophageal cancer	0.000113	0.00136	CcSEcCtD
Acitretin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000112	0.00135	CcSEcCtD
Acitretin—Vomiting—Cisplatin—esophageal cancer	0.000112	0.00135	CcSEcCtD
Acitretin—Fatigue—Capecitabine—esophageal cancer	0.000112	0.00135	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—esophageal cancer	0.000112	0.00134	CcSEcCtD
Acitretin—Rash—Cisplatin—esophageal cancer	0.000111	0.00134	CcSEcCtD
Acitretin—Constipation—Capecitabine—esophageal cancer	0.000111	0.00134	CcSEcCtD
Acitretin—Pain—Capecitabine—esophageal cancer	0.000111	0.00134	CcSEcCtD
Acitretin—Dermatitis—Cisplatin—esophageal cancer	0.000111	0.00133	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—esophageal cancer	0.00011	0.00132	CcSEcCtD
Acitretin—Feeling abnormal—Capecitabine—esophageal cancer	0.000107	0.00129	CcSEcCtD
Acitretin—Malaise—Methotrexate—esophageal cancer	0.000107	0.00128	CcSEcCtD
Acitretin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000106	0.00128	CcSEcCtD
Acitretin—Nausea—Cisplatin—esophageal cancer	0.000105	0.00126	CcSEcCtD
Acitretin—Cough—Methotrexate—esophageal cancer	0.000104	0.00124	CcSEcCtD
Acitretin—Urticaria—Capecitabine—esophageal cancer	0.000103	0.00124	CcSEcCtD
Acitretin—Abdominal pain—Capecitabine—esophageal cancer	0.000103	0.00123	CcSEcCtD
Acitretin—Body temperature increased—Capecitabine—esophageal cancer	0.000103	0.00123	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—esophageal cancer	0.000101	0.00121	CcSEcCtD
Acitretin—Chest pain—Methotrexate—esophageal cancer	0.000101	0.00121	CcSEcCtD
Acitretin—Myalgia—Methotrexate—esophageal cancer	0.000101	0.00121	CcSEcCtD
Acitretin—Discomfort—Methotrexate—esophageal cancer	9.99e-05	0.0012	CcSEcCtD
Acitretin—Infection—Methotrexate—esophageal cancer	9.63e-05	0.00116	CcSEcCtD
Acitretin—Hypersensitivity—Capecitabine—esophageal cancer	9.59e-05	0.00115	CcSEcCtD
Acitretin—Skin disorder—Methotrexate—esophageal cancer	9.41e-05	0.00113	CcSEcCtD
Acitretin—Hyperhidrosis—Methotrexate—esophageal cancer	9.37e-05	0.00112	CcSEcCtD
Acitretin—Asthenia—Capecitabine—esophageal cancer	9.34e-05	0.00112	CcSEcCtD
Acitretin—Anorexia—Methotrexate—esophageal cancer	9.24e-05	0.00111	CcSEcCtD
Acitretin—Pruritus—Capecitabine—esophageal cancer	9.21e-05	0.00111	CcSEcCtD
Acitretin—Diarrhoea—Capecitabine—esophageal cancer	8.91e-05	0.00107	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	8.83e-05	0.00106	CcSEcCtD
Acitretin—Insomnia—Methotrexate—esophageal cancer	8.76e-05	0.00105	CcSEcCtD
Acitretin—Paraesthesia—Methotrexate—esophageal cancer	8.7e-05	0.00104	CcSEcCtD
Acitretin—Somnolence—Methotrexate—esophageal cancer	8.61e-05	0.00103	CcSEcCtD
Acitretin—Dizziness—Capecitabine—esophageal cancer	8.61e-05	0.00103	CcSEcCtD
Acitretin—Dyspepsia—Methotrexate—esophageal cancer	8.53e-05	0.00102	CcSEcCtD
Acitretin—Decreased appetite—Methotrexate—esophageal cancer	8.42e-05	0.00101	CcSEcCtD
Acitretin—Gastrointestinal disorder—Methotrexate—esophageal cancer	8.37e-05	0.001	CcSEcCtD
Acitretin—Fatigue—Methotrexate—esophageal cancer	8.35e-05	0.001	CcSEcCtD
Acitretin—Pain—Methotrexate—esophageal cancer	8.29e-05	0.000994	CcSEcCtD
Acitretin—Vomiting—Capecitabine—esophageal cancer	8.28e-05	0.000993	CcSEcCtD
Acitretin—Rash—Capecitabine—esophageal cancer	8.21e-05	0.000985	CcSEcCtD
Acitretin—Dermatitis—Capecitabine—esophageal cancer	8.2e-05	0.000984	CcSEcCtD
Acitretin—Headache—Capecitabine—esophageal cancer	8.15e-05	0.000979	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—esophageal cancer	7.98e-05	0.000958	CcSEcCtD
Acitretin—Gastrointestinal pain—Methotrexate—esophageal cancer	7.92e-05	0.000951	CcSEcCtD
Acitretin—Nausea—Capecitabine—esophageal cancer	7.73e-05	0.000928	CcSEcCtD
Acitretin—Urticaria—Methotrexate—esophageal cancer	7.7e-05	0.000924	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—esophageal cancer	7.66e-05	0.000919	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—esophageal cancer	7.66e-05	0.000919	CcSEcCtD
Acitretin—Hypersensitivity—Methotrexate—esophageal cancer	7.14e-05	0.000857	CcSEcCtD
Acitretin—Asthenia—Methotrexate—esophageal cancer	6.95e-05	0.000834	CcSEcCtD
Acitretin—Pruritus—Methotrexate—esophageal cancer	6.86e-05	0.000823	CcSEcCtD
Acitretin—Diarrhoea—Methotrexate—esophageal cancer	6.63e-05	0.000796	CcSEcCtD
Acitretin—Dizziness—Methotrexate—esophageal cancer	6.41e-05	0.000769	CcSEcCtD
Acitretin—Vomiting—Methotrexate—esophageal cancer	6.16e-05	0.000739	CcSEcCtD
Acitretin—Rash—Methotrexate—esophageal cancer	6.11e-05	0.000733	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—esophageal cancer	6.1e-05	0.000733	CcSEcCtD
Acitretin—Headache—Methotrexate—esophageal cancer	6.07e-05	0.000728	CcSEcCtD
Acitretin—Nausea—Methotrexate—esophageal cancer	5.76e-05	0.000691	CcSEcCtD
Acitretin—RARA—Generic Transcription Pathway—NOTCH1—esophageal cancer	5.28e-05	0.000435	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	5.27e-05	0.000434	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SST—esophageal cancer	5.26e-05	0.000433	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	5.22e-05	0.00043	CbGpPWpGaD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	5.21e-05	0.000429	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PSME2—esophageal cancer	5.16e-05	0.000425	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PSME1—esophageal cancer	5.16e-05	0.000425	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—GHRL—esophageal cancer	5.13e-05	0.000422	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH3—esophageal cancer	5.13e-05	0.000422	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.1e-05	0.00042	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—CREBBP—esophageal cancer	5.09e-05	0.000419	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	5.07e-05	0.000417	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PSME2—esophageal cancer	5.06e-05	0.000417	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PSME1—esophageal cancer	5.06e-05	0.000417	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	5.05e-05	0.000416	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FBXW7—esophageal cancer	5.04e-05	0.000415	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	5.03e-05	0.000414	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SMG6—esophageal cancer	5.02e-05	0.000413	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC52A3—esophageal cancer	5.02e-05	0.000413	CbGpPWpGaD
Acitretin—RXRA—Metabolism—BLVRB—esophageal cancer	5.02e-05	0.000413	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—CREBBP—esophageal cancer	5e-05	0.000411	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH3—esophageal cancer	4.96e-05	0.000408	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.9e-05	0.000403	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CDKN1A—esophageal cancer	4.89e-05	0.000403	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH3—esophageal cancer	4.87e-05	0.000401	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.86e-05	0.0004	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PSME2—esophageal cancer	4.86e-05	0.0004	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PSME1—esophageal cancer	4.86e-05	0.0004	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PSME2—esophageal cancer	4.86e-05	0.0004	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PSME1—esophageal cancer	4.86e-05	0.0004	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—CREBBP—esophageal cancer	4.79e-05	0.000394	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—CREBBP—esophageal cancer	4.79e-05	0.000394	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH3—esophageal cancer	4.78e-05	0.000393	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NOTCH2—esophageal cancer	4.78e-05	0.000393	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.7e-05	0.000387	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH2—esophageal cancer	4.6e-05	0.000379	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH3—esophageal cancer	4.58e-05	0.000377	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH3—esophageal cancer	4.58e-05	0.000377	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CYP1B1—esophageal cancer	4.57e-05	0.000376	CbGpPWpGaD
Acitretin—RBP1—Disease—HIF1A—esophageal cancer	4.51e-05	0.000371	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ATP1B2—esophageal cancer	4.51e-05	0.000371	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.48e-05	0.000369	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH2—esophageal cancer	4.45e-05	0.000366	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH2—esophageal cancer	4.37e-05	0.00036	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	4.37e-05	0.00036	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.33e-05	0.000357	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CYP19A1—esophageal cancer	4.3e-05	0.000354	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH2—esophageal cancer	4.29e-05	0.000353	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CA1—esophageal cancer	4.27e-05	0.000351	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC10A2—esophageal cancer	4.27e-05	0.000351	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	4.25e-05	0.00035	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.21e-05	0.000346	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	4.15e-05	0.000342	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.12e-05	0.000339	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH2—esophageal cancer	4.11e-05	0.000338	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH2—esophageal cancer	4.11e-05	0.000338	CbGpPWpGaD
Acitretin—RBP1—Disease—NOS2—esophageal cancer	4.11e-05	0.000338	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TGFBR2—esophageal cancer	4.08e-05	0.000336	CbGpPWpGaD
Acitretin—ALB—Hemostasis—DOCK2—esophageal cancer	4.08e-05	0.000336	CbGpPWpGaD
Acitretin—RBP1—Disease—NOTCH1—esophageal cancer	4.07e-05	0.000335	CbGpPWpGaD
Acitretin—RARG—Gene Expression—SMAD4—esophageal cancer	4.01e-05	0.00033	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—HMOX1—esophageal cancer	3.92e-05	0.000323	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	3.91e-05	0.000321	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CA2—esophageal cancer	3.9e-05	0.000321	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SMAD4—esophageal cancer	3.86e-05	0.000318	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.81e-05	0.000314	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NR1I2—esophageal cancer	3.8e-05	0.000313	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ABCB1—esophageal cancer	3.77e-05	0.00031	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—SMAD4—esophageal cancer	3.73e-05	0.000307	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.72e-05	0.000306	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	3.7e-05	0.000305	CbGpPWpGaD
Acitretin—RBP1—Disease—CREBBP—esophageal cancer	3.69e-05	0.000303	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SMAD4—esophageal cancer	3.67e-05	0.000302	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ABL1—esophageal cancer	3.63e-05	0.000299	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PLCE1—esophageal cancer	3.63e-05	0.000299	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ADH7—esophageal cancer	3.63e-05	0.000299	CbGpPWpGaD
Acitretin—RARB—Gene Expression—SMAD4—esophageal cancer	3.6e-05	0.000296	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.6e-05	0.000296	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	3.59e-05	0.000295	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.58e-05	0.000295	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	3.53e-05	0.000291	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PFN1—esophageal cancer	3.52e-05	0.00029	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SMAD4—esophageal cancer	3.52e-05	0.000289	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	3.49e-05	0.000287	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SMAD4—esophageal cancer	3.45e-05	0.000284	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SMAD4—esophageal cancer	3.45e-05	0.000284	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.42e-05	0.000282	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	3.39e-05	0.000279	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	3.39e-05	0.000279	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—MYC—esophageal cancer	3.31e-05	0.000272	CbGpPWpGaD
Acitretin—RBP1—Disease—NOS3—esophageal cancer	3.3e-05	0.000272	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HIST1H2BM—esophageal cancer	3.26e-05	0.000269	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ADH1B—esophageal cancer	3.18e-05	0.000262	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HIF1A—esophageal cancer	3.16e-05	0.00026	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.11e-05	0.000256	CbGpPWpGaD
Acitretin—RBP1—Disease—ERBB2—esophageal cancer	3.09e-05	0.000254	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMP—esophageal cancer	3.04e-05	0.00025	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MYC—esophageal cancer	3.02e-05	0.000249	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KDR—esophageal cancer	3.02e-05	0.000249	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—esophageal cancer	3.02e-05	0.000248	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.99e-05	0.000246	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.98e-05	0.000245	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—esophageal cancer	2.96e-05	0.000244	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NOTCH1—esophageal cancer	2.96e-05	0.000243	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP26A1—esophageal cancer	2.96e-05	0.000243	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.95e-05	0.000243	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.92e-05	0.00024	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALOX15—esophageal cancer	2.88e-05	0.000237	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CFL1—esophageal cancer	2.85e-05	0.000235	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH1—esophageal cancer	2.85e-05	0.000234	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—esophageal cancer	2.84e-05	0.000234	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—esophageal cancer	2.84e-05	0.000234	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH1—esophageal cancer	2.75e-05	0.000227	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KDR—esophageal cancer	2.75e-05	0.000226	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTO1—esophageal cancer	2.75e-05	0.000226	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TPI1—esophageal cancer	2.75e-05	0.000226	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH1—esophageal cancer	2.71e-05	0.000223	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MET—esophageal cancer	2.69e-05	0.000222	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GNG7—esophageal cancer	2.69e-05	0.000221	CbGpPWpGaD
Acitretin—RARG—Gene Expression—CREBBP—esophageal cancer	2.68e-05	0.000221	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH1—esophageal cancer	2.65e-05	0.000218	CbGpPWpGaD
Acitretin—RBP1—Disease—CDKN1A—esophageal cancer	2.64e-05	0.000217	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALDOB—esophageal cancer	2.64e-05	0.000217	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—esophageal cancer	2.61e-05	0.000215	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NOTCH1—esophageal cancer	2.59e-05	0.000213	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CREBBP—esophageal cancer	2.58e-05	0.000212	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.57e-05	0.000212	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	2.57e-05	0.000211	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH1—esophageal cancer	2.54e-05	0.000209	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH1—esophageal cancer	2.54e-05	0.000209	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GAPDH—esophageal cancer	2.54e-05	0.000209	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.53e-05	0.000208	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PSME2—esophageal cancer	2.53e-05	0.000208	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PSME1—esophageal cancer	2.53e-05	0.000208	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CREBBP—esophageal cancer	2.52e-05	0.000207	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CRABP1—esophageal cancer	2.51e-05	0.000207	CbGpPWpGaD
Acitretin—RBP1—Disease—EP300—esophageal cancer	2.51e-05	0.000207	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—CREBBP—esophageal cancer	2.5e-05	0.000205	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—CREBBP—esophageal cancer	2.45e-05	0.000202	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.45e-05	0.000202	CbGpPWpGaD
Acitretin—RARB—Gene Expression—CREBBP—esophageal cancer	2.41e-05	0.000198	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GNG7—esophageal cancer	2.39e-05	0.000197	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH3—esophageal cancer	2.39e-05	0.000197	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CREBBP—esophageal cancer	2.35e-05	0.000193	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.33e-05	0.000192	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOS3—esophageal cancer	2.31e-05	0.00019	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—CREBBP—esophageal cancer	2.31e-05	0.00019	CbGpPWpGaD
Acitretin—RARA—Gene Expression—CREBBP—esophageal cancer	2.31e-05	0.00019	CbGpPWpGaD
Acitretin—ALB—Metabolism—BLVRB—esophageal cancer	2.29e-05	0.000188	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC52A3—esophageal cancer	2.29e-05	0.000188	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—NOS3—esophageal cancer	2.25e-05	0.000185	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALDH2—esophageal cancer	2.24e-05	0.000184	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HSPA5—esophageal cancer	2.19e-05	0.00018	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—esophageal cancer	2.19e-05	0.00018	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—esophageal cancer	2.16e-05	0.000178	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH2—esophageal cancer	2.14e-05	0.000176	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—esophageal cancer	2.14e-05	0.000176	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTT1—esophageal cancer	2.13e-05	0.000175	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2A6—esophageal cancer	2.11e-05	0.000173	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.1e-05	0.000173	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—esophageal cancer	2.06e-05	0.00017	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.05e-05	0.000168	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS1—esophageal cancer	2e-05	0.000164	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO1—esophageal cancer	2e-05	0.000164	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2e-05	0.000164	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PSME1—esophageal cancer	1.97e-05	0.000162	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PSME2—esophageal cancer	1.97e-05	0.000162	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—esophageal cancer	1.97e-05	0.000162	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC10A2—esophageal cancer	1.95e-05	0.00016	CbGpPWpGaD
Acitretin—ALB—Metabolism—CA1—esophageal cancer	1.95e-05	0.00016	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—esophageal cancer	1.91e-05	0.000157	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—esophageal cancer	1.86e-05	0.000153	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1A—esophageal cancer	1.85e-05	0.000152	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SMAD4—esophageal cancer	1.8e-05	0.000148	CbGpPWpGaD
Acitretin—ALB—Metabolism—CA2—esophageal cancer	1.78e-05	0.000146	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EP300—esophageal cancer	1.76e-05	0.000145	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.74e-05	0.000143	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.72e-05	0.000141	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—EP300—esophageal cancer	1.71e-05	0.000141	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1B1—esophageal cancer	1.7e-05	0.00014	CbGpPWpGaD
Acitretin—ALB—Metabolism—ADH7—esophageal cancer	1.65e-05	0.000136	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLCE1—esophageal cancer	1.65e-05	0.000136	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.64e-05	0.000135	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ABL1—esophageal cancer	1.62e-05	0.000134	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EP300—esophageal cancer	1.6e-05	0.000132	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP19A1—esophageal cancer	1.6e-05	0.000131	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—esophageal cancer	1.59e-05	0.000131	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—esophageal cancer	1.53e-05	0.000126	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—esophageal cancer	1.5e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—esophageal cancer	1.48e-05	0.000122	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HMOX1—esophageal cancer	1.46e-05	0.00012	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—esophageal cancer	1.46e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Metabolism—ADH1B—esophageal cancer	1.45e-05	0.000119	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.43e-05	0.000118	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—esophageal cancer	1.43e-05	0.000118	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.42e-05	0.000117	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCB1—esophageal cancer	1.4e-05	0.000115	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMP—esophageal cancer	1.39e-05	0.000114	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—esophageal cancer	1.37e-05	0.000113	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—esophageal cancer	1.37e-05	0.000113	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—esophageal cancer	1.36e-05	0.000112	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.36e-05	0.000112	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP26A1—esophageal cancer	1.35e-05	0.000111	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH1—esophageal cancer	1.33e-05	0.000109	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALOX15—esophageal cancer	1.31e-05	0.000108	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—esophageal cancer	1.3e-05	0.000107	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—esophageal cancer	1.27e-05	0.000104	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—esophageal cancer	1.26e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTO1—esophageal cancer	1.25e-05	0.000103	CbGpPWpGaD
Acitretin—ALB—Metabolism—TPI1—esophageal cancer	1.25e-05	0.000103	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALDOB—esophageal cancer	1.2e-05	9.89e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CREBBP—esophageal cancer	1.2e-05	9.89e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NOS2—esophageal cancer	1.17e-05	9.64e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GAPDH—esophageal cancer	1.16e-05	9.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CRABP1—esophageal cancer	1.15e-05	9.44e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GNG7—esophageal cancer	1.09e-05	8.98e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.06e-05	8.7e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CREBBP—esophageal cancer	1.05e-05	8.65e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	1.03e-05	8.46e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALDH2—esophageal cancer	1.02e-05	8.41e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTT1—esophageal cancer	9.72e-06	8e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2A6—esophageal cancer	9.61e-06	7.91e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.57e-06	7.88e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NOS3—esophageal cancer	9.41e-06	7.75e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CREBBP—esophageal cancer	9.35e-06	7.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO1—esophageal cancer	9.11e-06	7.5e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS1—esophageal cancer	9.11e-06	7.5e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.1e-06	7.49e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PSME1—esophageal cancer	8.98e-06	7.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PSME2—esophageal cancer	8.98e-06	7.39e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NOS3—esophageal cancer	8.37e-06	6.89e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.84e-06	6.45e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1B1—esophageal cancer	7.74e-06	6.37e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—esophageal cancer	7.65e-06	6.3e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP19A1—esophageal cancer	7.28e-06	5.99e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EP300—esophageal cancer	7.16e-06	5.89e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—esophageal cancer	7.13e-06	5.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HMOX1—esophageal cancer	6.64e-06	5.47e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.52e-06	5.37e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCB1—esophageal cancer	6.38e-06	5.25e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—EP300—esophageal cancer	6.36e-06	5.24e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—esophageal cancer	5.3e-06	4.36e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—esophageal cancer	5.12e-06	4.22e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.82e-06	3.97e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—esophageal cancer	4.71e-06	3.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CREBBP—esophageal cancer	4.26e-06	3.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NOS3—esophageal cancer	3.82e-06	3.14e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—esophageal cancer	3.49e-06	2.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—EP300—esophageal cancer	2.9e-06	2.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—esophageal cancer	2.15e-06	1.77e-05	CbGpPWpGaD
